Introduction
Alzheimer disease (AD) is a degenerative brain disorder and a leading cause of dementia that affects 47 million people worldwide 1 . AD is caused by pathological increase of amyloid β (Aβ) in the brain, resulting from an imbalance between its 5 production and clearance. Recent studies suggest that accumulation of Aβ in the brain begins at least 20 years before symptoms appear 2 . Although several promising drugs targeting the amyloid cascade have been developed, their astoundingly high failure rates (99.6%) in the clinic suggest that by the time amyloid plaques, neurofibrillary tangles and neuronal death are detected, it is unlikely that disease progression can be 10 halted and reversed 3 . Identifying and targeting pre-clinical pathologies may be critical for an effective cure.
In this context, endosomal aberrations constitute the earliest detectable brain cytopathology, emerging before cognitive dysfunction is apparent in neurodegenerative disorders, including Alzheimer disease, Niemann-Pick Type C and Down syndrome 4, 5, 15 6, 7 . Consistent with this finding, genes associated with endosomal trafficking have been implicated as major risk factors in AD 8 . Importantly, prominent pre-symptomatic endosomopathy of the brain, evidenced by enlarged and more numerous endosomes, has been observed in the ApoE4 genotype 9, 10, 11 , the strongest known genetic risk factor influencing susceptibility to sporadic, late-onset AD (LOAD) 12, 13 . The pathological 20 E4 variant of Apolipoprotein E is present in ~50% of patients with AD, and the presence of two copies of the E4 allele increases risk of LOAD by ∼12-times as compared to E3 isoform 14 . Yet, despite strong evidence implicating endosomal uptake and clearance of Aβ in mediating AD risk in the ApoE4 genotype 14, 15, 16 , the underlying mechanism is unknown.
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Here we show that a profound dysregulation of endosomal pH in humanized mouse ApoE4 astrocytes leads to intracellular sequestration and cell surface loss of the 17, 18 . In summary, we identify NHE6 as a novel ApoE effector and suggest potential therapeutic options in the treatment of amyloid disorders.
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Results
ApoE4 astrocytes have cargo specific defects in endocytosis
Studies in human, mouse models and cell-culture have revealed the 15 importance of ApoE-isotype-specific differences in Aβ uptake and clearance in AD pathogenesis, although the underlying mechanism remains to be determined 14, 16, 19, 20 . To this end, we developed a sensitive and quantitative fluorescent-based assay to monitor cell-associated Aβ peptide ( to ApoE3 at all time points (Fig. 1C, Fig. S1F ). In contrast, cell-associated TFN was 1.5-2 fold higher in ApoE4 cells relative to ApoE3 as measured by flow cytometry (Fig. 1D ) 5 and confocal microscopy ( Fig. 1E ). Uptake of dextran by fluid-phase endocytosis was not different between ApoE genotypes (Fig. 1F ). These observations reveal cargo selective effects of ApoE isotype in astrocytes and point to alterations in specific receptor pathways.
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Surface expression of LRP1 receptor is severely reduced in ApoE4 astrocytes
Transcriptional down regulation of the LRP1 receptor has been suggested as an underlying mechanism for defective Aβ clearance in AD patients 21 . However, we found no difference in brain LRP1 gene expression at different stages of AD (incipient, 10 moderate, and severe), as compared with normal controls, in publicly available microarray data 22 ( Fig. S2A-B ). Meta-analysis of nine independent gene expression studies from anatomically and functionally distinct brain regions, comprising a total of 103 AD and 87 control post-mortem brains also showed no significant changes in LRP1 gene expression in AD (Fig. S2C-D) . Consistent with these findings, we observed no 15 differences in LRP1 transcript and total protein expression between ApoE3 and ApoE4
astrocytes (Fig. S2E-G).
LRP1 undergoes constitutive endocytosis from the membrane and recycling back to the cell surface 23 . Therefore we considered the possibility that alterations in LRP1 receptor recycling could result in differences in plasma membrane expression. ApoE 20 isotype-specific surface expression of LRP1 was evaluated using four independent approaches ( Fig. 2A) . First, surface biotinylation revealed that plasma membrane expression of LRP1 receptor in ApoE4 astrocytes was lower by ∼50% (Fig. 1B) .
Second, an antibody directed against an external epitope of LRP1 to quantify surface expression in live cells by flow cytometry analysis showed a reduction of LRP1-positive 25 cells by ~43% (Fig. 1C) . Third, this was confirmed by confocal microscopy showing ∼49% lower LRP1 surface labeling by antibody in ApoE4 (Fig. 1D) . In a fourth approach, surface-bound ligand (fluorescent Aβ) measured by confocal microscopy was 66% lower in ApoE4 astrocytes (Fig. 1E) . Notably, the greater attenuation in Aβ binding when compared to the ∼50% reduction in surface LRP1 levels suggests additional 
Endo-lysosomal pH is defective in ApoE4 astrocytes
The pH within the endo-lysosomal system plays a critical role in receptormediated endocytosis and recycling 24 . We used compartment-specific, pH-sensitive 10 fluorescence reporters to probe ApoE-isotype dependent differences in endosomal, lysosomal and cytoplasmic pH (Fig. 3A) . Endosomal pH in ApoE4 astrocytes was strongly reduced by ∼0.84 pH unit, relative ApoE3 (Fig. 3B ). In contrast, we observed >1 pH unit elevation of lysosomal pH in ApoE4 astrocytes (Fig. 3C) . Previously, elevated lysosomal pH was observed in presenilin 1 (PS1)-deficient cell culture models 15 and neurons, another genetic model of AD 25 . Cytoplasmic pH showed no significant differences between the two ApoE isotypes (Fig. 3D ). ApoE3, it was ∼56% reduced in ApoE4 knock-in cells (Fig. 4C ). There was also ApoE4 specific reduction in transcript for the related endosomal isoform NHE9 (∼70% lower) and lysosomal V-ATPase V0a1 subunit (~67%), but not for the plasma membrane 20 NHE1 isoform (Fig. S3B) . These large transcript differences could account for the observed ApoE-isotype specific shifts in endo-lysosomal pH.
Taken together, these data suggest an important, hitherto underappreciated role of proton transport and endosomal pH regulation in AD. We hypothesized that NHE6 is a potential ApoE effector, and that down regulation of NHE6 in disease-associated
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ApoE4 variants is causal to a subset of AD phenotypes. Consistent with this hypothesis, amyloid Aβ levels were found to be elevated in mouse brains from NHE6 KO (Fig. 4C ), together with diminished brain weight (Fig. S3C) , suggesting an underlying neurodegenerative pathology.
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Similar to monensin treatment, lentiviral vector mediated expression of NHE6 alkalinized the endosomal lumen in ApoE4 astrocytes (Fig. S3D ). Therefore, we tested if ectopic expression of GFP-tagged eNHE isoforms could correct defective Aβ uptake in ApoE4 astrocytes. Remarkably, Aβ clearance was restored to ApoE3 levels in ApoE4 astrocytes transfected with NHE6 ( Fig. 4E ), but not with NHE9 ( Fig. S3E-F Dysfunction in endo-lysosomal pH is an emerging theme in AD with clear potential for intervention to exploit the disease-modifying effects of endosomal pH 7 .
5
Amphipathic drugs such as bepridil and amiodarone partition into acidic compartments, alkalinize endosomes, and correct Aβ pathology in cell culture and animal models 47 .
Our study supports a rational, mechanistic basis for such repurposing of existing FDAapproved drugs with well-established safety and pharmacokinetic profiles, known to have off-label activity of endosomal alkalization, to target the cellular microenvironment 
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Student's t-test).
Fig. 3: Endo-lysosomal pH is defective in ApoE4 astrocytes
A. Compartment-specific, ratiometric, pH-sensitive fluorescence reporters to probe ApoE-isotype dependent differences in endosomal, lysosomal and cytoplasmic pH. Cytoplasmic pH was measured ratiometrically using pH-sensitive green and pH non- 
Aβ assay on mouse brain
The human/rat/mouse β amyloid ELISA kit was from Wako (#294-64701) was used for the estimation of Aβ40 levels in brain homogenates, as per manufacturer's instructions.
Briefly, brains of mice were dissected on ice, weighed and homogenized in ice-old RIPA buffer (PBS+ 1% Triton+ 0.1% SDS+ 0.5% deoxycholate) containing protease inhibitor 25 (Roche). Lysate was centrifuged for 8-10 minutes at 8,000-9,000 rpm and supernatant 31 was collected and used for ELISA. BCA method was used to measure the total protein concentrations. Aβ40 was normalized to total protein concentration in the lysate.
Endosomal, lysosomal and cytoplasmic pH measurement
Detailed protocols are provided in the Extended Experimental Procedures
Statistical Analysis
5
All data were analyzed statistically by Student's t test, ANOVA and linear regression test using GraphPad Prism. All data are presented as mean ± SD.
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SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and four figures.
Extended Experimental Procedures
Antibodies and Reagents
Mouse monoclonal antibodies used were External epitope Anti-LRP1 (#ab20753, in a 5% CO 2 incubator at 37°C. Cell viability was measured using the trypan blue exclusion method.
Plasmids and transfection
NHE6-GFP and NHE9-GFP were cloned into FUGW-lentiviral vector into the BamHI site. Astrocytes were transfected using lentiviral packaging and expression.
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Bioinformatics
Mammalian gene expression datasets included in the study were GSE5281, GSE1297, GSE4757, GSE5281, GSE16759, E-MEXP-2280, and GSE15222. Gene Ontology (GO) enrichment analysis was performed using tools provided at the GO web site (http://www.geneontology.org). Pooled analysis was performed using the RevMan 5 program (Nordic Cochrane Centre), as previously described 43 .
Transferrin and dextran uptake
Steady state transferrin uptake was measured using flow cytometry and confocal microscopy, as we previously described 28, 43 . Briefly, cells were rinsed and incubated in serum-free medium for 30min, to remove residual transferrin and then incubated with Pearson's correlation coefficient, using the JACoP ImageJ plugin that measures the direct overlap of pixels in the confocal section, and represented it as mean ± S.E.
Western blot and surface biotinylation
Cells were lysed using 1% Nonidet P-40 (Sigma) supplemented with protease inhibitor cocktail (Roche system was used to capture images and densitometric quantification was done using ImageJ software.
Endosomal pH measurement
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Endosomal pH was measured using flow cytometry, as we previously described 28, 43 .
Briefly, cells were rinsed and incubated in serum-free medium for 30min, to remove 
Lysosomal pH measurement
Lysosomal pH was measured as previously described, with modifications 25 . Briefly, cells
were rinsed and incubated with pH-sensitive pHrodo-green-Dextran (#P35368, Thermo
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Fisher Scientific) (5 µg/ml) together with pH non-sensitive Alexa Fluor 647-Dextran (#D22914, Thermo Fisher Scientific) (10 µg/ml) for 12 hours, washed then chased in dye free media for additional 6 hours. Cells were trypsinized and pH was determined by flow cytometry analysis of ∼10,000 cells in biological triplicates using the FACSAria instrument (BD Biosciences). A four-point calibration curve with different pH values (3.5, 5 4.5, 5.5 and 6.5) was generated in the presence of 10µM K + /H + ionophore nigericin and 10µM K + ionophore valinomycin.
Cytoplasmic pH measurement
Cytoplasmic pH was measured using flow cytometry as we previously described 29 .
Briefly, cells were washed and incubated with 1µM BCECF-AM (Thermo Fisher 
Aβ surface-binding assay
Ligand surface-binding assay was performed as we previously described, with modifications 29 . Cells on coverslips were rinsed and incubated in serum-free medium for 30min and then exposed to 100 nM fluorescently-labeled HiLyte Fluor 647-Aβ40
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(#AS-64161, AnaSpec) in 1% BSA solution on ice for 10min, followed by subsequent washes with PBS at pH 7.0. Cells were then fixed, DAPI stained and mounted onto slides to quantify Aβ surface-binding by confocal microscopy.
HDAC nuclear translocation
For quantifying HDAC4 nuclear translation, we immunostained cells using a mouse 20 monoclonal antibody against HDAC4 (#5392, Cell Signaling Technology) and confocal microscopy images were analyzed to measure colocalization between HDAC4 and nuclear stain DAPI. Next, we performed nuclear fractionation of cultured cells using
Nuclei isolation kit (#NUC-101, Sigma), as per manufacturer's instructions. Protein concentration was determined using the BCA assay. Protein from nuclear lysate was 25 resolved using SDS-PAGE and transferred to nitrocellulose membranes. The
